To date, the CPS score has been developed to predict the response to anti-PD-1 therapy in cancer patients (4), while our results demonstrated the expression levels of PD-L1 CPS expression did not significantly correlate (Figure 2D). The gene discussed is PDCD1; the disease is cancer.